Report: Bayer weighing sale of $10B plastics unit

• Bayer (OTCPK:BAYRY, OTCPK:BAYZF) is exploring a sale of its $10B plastics unit to focus on expanding its health business, according to a Bloomberg reports.
• Bayer reportedly is considering the options for Bayer Material Science after crosstown chemicals company Evonik (OTCPK:EVKIF) showed potential interest several months ago.
• A sale of the plastics unit would take time to carve out and would coincide with a push by Bayer to make acquisitions to broaden its drug and life-science offering.